Page 132 - Read Online

Page 22 of 25 Luo et al. Microbiome Res Rep 2025;4:10 https://dx.doi.org/10.20517/mrr.2024.57

DOI PubMed PMC
99. Yoon W, Yoo Y, Chae YS, Kee SH, Kim BM. Therapeutic advantage of genetically engineered Salmonella typhimurium carrying
short hairpin RNA against inhibin alpha subunit in cancer treatment. Ann Oncol 2018;29:2010-7. DOI PubMed
100. Zheng JH, Nguyen VH, Jiang SN, et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium
secreting heterologous flagellin. Sci Transl Med 2017;9:eaak9537. DOI
101. Tan W, Duong MT, Zuo C, et al. Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella
typhimurium. Mol Ther 2022;30:662-71. DOI PubMed PMC
102. Satoh Y, Kotani H, Iida Y, Taniura T, Notsu Y, Harada M. Supplementation of l-arginine boosts the therapeutic efficacy of anticancer
chemoimmunotherapy. Cancer Sci 2020;111:2248-58. DOI PubMed PMC
103. Canale FP, Basso C, Antonini G, et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature
2021;598:662-6. DOI
104. Reich N, Hölscher C. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: an in-depth
review. Front Neurosci 2022;16:970925. DOI PubMed PMC
105. Diz-Chaves Y, Mastoor Z, Spuch C, González-Matías LC, Mallo F. Anti-inflammatory effects of GLP-1 receptor activation in the
brain in neurodegenerative diseases. Int J Mol Sci 2022;23:9583. DOI PubMed PMC
106. Nowell J, Blunt E, Edison P. Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease. Mol
Psychiatry 2023;28:217-29. DOI PubMed PMC
107. Batista AF, Bodart-Santos V, De Felice FG, Ferreira ST. Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in
Alzheimer’s and Parkinson’s diseases. CNS Drugs 2019;33:209-23. DOI PubMed
108. Wang RF, Xue GF, Hölscher C, et al. Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and
mitochondrial stress induced by Status epilepticus. Epilepsy Res 2018;142:45-52. DOI
109. Loh JS, Mak WQ, Tan LKS, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal
Transduct Target Ther 2024;9:37. DOI PubMed PMC
110. Chen T, Tian P, Huang Z, et al. Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and
amyloidogenesis via producing GLP-1. Appl Microbiol Biotechnol 2018;102:7565-75. DOI
111. Yue M, Wei J, Chen W, Hong D, Chen T, Fang X. Neurotrophic role of the next-generation probiotic strain L. lactis MG1363-
pMG36e-GLP-1 on Parkinson’s disease via inhibiting ferroptosis. Nutrients 2022;14:4886. DOI PubMed PMC
112. Fang X, Tian P, Zhao X, Jiang C, Chen T. Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-
1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1. J Neurochem 2019;150:441-52.
DOI PubMed
113. Mukherjee S, Bassler BL. Bacterial quorum sensing in complex and dynamically changing environments. Nat Rev Microbiol
2019;17:371-82. DOI PubMed PMC
114. Gupta RK, Luong TT, Lee CY. RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing
mRNA. Proc Natl Acad Sci U S A 2015;112:14036-41. DOI PubMed PMC
115. Lubkowicz D, Ho CL, Hwang IY, Yew WS, Lee YS, Chang MW. Reprogramming probiotic Lactobacillus reuteri as a biosensor for
staphylococcus aureus derived AIP-I detection. ACS Synth Biol 2018;7:1229-37. DOI PubMed
116. Li H, Jia M, Qi Q, Wang Q. Engineered probiotic Lactobacillus plantarum WCSF I for monitoring and treatment of Staphylococcus
aureus infection. Microbiol Spectr 2023;11:e0182923. DOI PubMed PMC
117. Mao N, Cubillos-Ruiz A, Cameron DE, Collins JJ. Probiotic strains detect and suppress cholera in mice. Sci Transl Med
2018;10:eaao2586. DOI PubMed PMC
118. Borrero J, Chen Y, Dunny GM, Kaznessis YN. Modified lactic acid bacteria detect and inhibit multiresistant enterococci. ACS Synth
Biol 2015;4:299-306. DOI PubMed PMC
119. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS 2010;5:463-6. DOI PubMed PMC
120. Mimee M, Nadeau P, Hayward A, et al. An ingestible bacterial-electronic system to monitor gastrointestinal health. Science
2018;360:915-8. DOI PubMed PMC
121. Zou ZP, Du Y, Fang TT, Zhou Y, Ye BC. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates
inflammatory bowel disease in mice. Cell Host Microbe 2023;31:199-212.e5. DOI
122. Xia JY, Hepler C, Tran P, Waldeck NJ, Bass J, Prindle A. Engineered calprotectin-sensing probiotics for IBD surveillance in humans.
Proc Natl Acad Sci U S A 2023;120:e2221121120. DOI PubMed PMC
123. Meng T, Ma W, Fan M, Tang W, Duan X. Enhancing the contrast of tumor imaging for image-guided surgery using a tumor-targeting
probiotic with the continuous expression of a biomarker. Anal Chem 2022;94:10109-17. DOI PubMed
124. Danino T, Prindle A, Kwong GA, et al. Programmable probiotics for detection of cancer in urine. Sci Transl Med 2015;7:289ra84.
DOI PubMed PMC
125. Tanniche I, Behkam B. Engineered live bacteria as disease detection and diagnosis tools. J Biol Eng 2023;17:65. DOI PubMed
PMC
126. Perdigon G, Alvarez S, Nader DE Macias ME, Roux ME, de Ruiz Holgado AP. The oral administration of lactic acid bacteria
increase the mucosal intestinal immunity in response to enteropathogens. J Food Prot 1990;53:404-10. DOI PubMed
127. Hanniffy SB, Carter AT, Hitchin E, Wells JM. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords
protection against respiratory infection. J Infect Dis 2007;195:185-93. DOI PubMed